Market announcement

AS PRFoods

LEI code

529900PFXFO2ZDCRNK93

Size of the entity

Medium group

Economic activities

Financial and Insurance Activities

Country of registered office

Estonia

General information

Categories

Other corporate action

Unique data record identifier

8024

Submission date and time

17.05.2020 19:37:53

Content of announcement in Estonian

Title

PRF: AS-i PRFoods 2019/2020 majandusaasta 3. kvartali ja 9 kuu konsolideeritud auditeerimata vahearuanne

Message

ÜLEVAADE MAJANDUSTEGEVUSEST

Majandusaasta 3. kvartal lõppes PRFoodsile 2%-lise müügikasvuga, kokku oli käive
18,5 miljonit eurot (9 kuud 63,2 miljonit eurot).  9 kuu EBITDA kasvas 35% võrra
2 miljoni euroni ning puhaskahjum vähenes 25% võrra 0,6 miljoni euroni võrreldes
eelmise aasta sama perioodiga.

Kvartali  lõpp  tõi  ülemaailmse  pandeemia  jõudmise  meie  põhiturgudele  ning
eriolukorraga  seotud piirangud  hakkasid avaldama  mõju. HoReCa  piirangud ning
lennutranspordi  drastiline  vähenemine  mõjutasid  märkimisväärselt käivet juba
märtsi  lõpus.  Samuti,  nagu  iga  kriisi  ajal, tegid kliendid oma toidukorvis
muudatusi, eelistades odavamaid tooteid. PRFoods läks Covid-19 pandeemiale vastu
tugevdatud  bilansiga, kuna olime just  refinantseerinud oma lühiajalised laenud
võlakirjadega ning samuti oleme parandanud oma rahavoogusid tingituna väiksemast
tooraine  laost.  Suuremad  muutused  seisavad  ees  4. kvartalis, aga näeme, et
vähemalt  juunis on osaliselt taastumas  HoReCa (osakaal Grupi käibest 25%) ning
toiduainetetööstused  on turvalisemas seisus kui paljud muud sektorid. Covid-19
mõju  PRFoods majandustulemustele  kajastame finantsaasta  4. kvartali ja 12 kuu
majandustulemustes.

Grupi müügitulu

Grupi  auditeerimata konsolideeritud käive  finantsaasta 3. kvartalis (so 2020.
aasta  1. kv) oli 18,5 milj.  eurot, suurenedes 2% võrreldes  eelmise aasta sama
perioodiga  (2019. aasta  1. kv: 18,2 miljonit  eurot). Grupi finantsaasta 9 kuu
käive  oli  63,2 milj.  eurot  jäädes  eelmise  aasta sama perioodiga pea samale
tasemele  (9 kuud  2018/2019: 64,2 milj.eurot). Aasta  esimeses kvartalis kasvas
värske  kala- ja  kalafilee müük  24% ning suitsutatud  toodete müük langes 12 %
võrreldes  eelmise  aasta  sama  perioodiga.  Märtsi  käivet  mõjutas  oluliselt
müügilangus   HoReCa   segmendis   (36%)  seoses  Covid-19 pandeemiast  tuleneva
eriolukorra kehtestamisega nii Soomes kui Eestis.

Majandusaasta  9 kuu kokkuvõttes on toore kala ja -filee osakaal tooteportfellis
kasvanud  45 %-ni (kasv 4 pp võrreldes eelmise sama perioodiga) ning suitsutatud
toodete osakaal langenud 38%-ni (vähenemine vastavalt 5 pp).

Värske  kala ja -filee müük on  olnud eelmainitud perioodil kõrgema marginaaliga
kui tavaliselt, samas on värske kala marginaal ca kaks korda väiksem suitsutatud
toodete marginaalist.

Finantsaasta 3. kvartali ja 9 kuu tulemus

Grupi   9 kuu   konsolideeritud   EBITDA   oli   2,0 miljonit   eurot   (9  kuud
2018/2019: 1,5 milj. eurot), suurenedes eelmise aastaga võrreldes 35%, tulenedes
peamiselt  bioloogiliste varade  ümberhindluse positiivsest  mõjust. Äritegevuse
EBITDA  (s.o enne  ühekordseid tulusid-kulusid  ja kalavarude ümberhindlust) oli
2,9 miljonit  eurot (9 kuud  2018/2019: 3,7 miljonit eurot). Puhaskahjum vähenes
kuni 0,6 miljoni euroni (9 kuud 2018/2019 puhaskahjum: 0,8 miljonit eurot).

Finantsaasta  3. kvartali  äritegevuse  EBITDA  oli  0,03 milj. eurot (3.kvartal
2018/2019: 0,21 milj.   eurot)  ning  puhaskahjum  1,7 milj.  eurot,  suurenedes
eelmise  aasta sama perioodiga 0,5 milj. eurot (3. kvartal 2018/2019: -1,2 milj.
eurot).  Bioloogiliste  varade  õiglase  väärtuse  ümberhindluse negatiivne mõju
EBITDA-le  oli   0,75 miljonit  eurot  (3kv  2018/2019:  negatiivne  mõju  0,46
miljonit   eurot).   Aruandeperioodi   kõrgemate   finantskulude  põhjusteks  on
laenuintressist   (3,25%)   kõrgem  võlakirjaintress  (6,25%)  (negatiivne  mõju
kvartali  kasumile 0,03 milj.  eurot) ning  Rootsi krooni  nõrgenemisest tulenev
kursikahjum (-0,15 miljonit eurot).

Positiivne   on  grupi  EBITDA  kasv  35% võrra  2 miljonini  3.kvartali lõpuks,
eelkõige   tänu   bioloogiliste  varade  kasvule.  Äritegevuse  EBITDAd  mõjutas
suitsutatud  toodete osakaalu vähenemine käibes,  mis tulenes aasta alguse Soome
müügikoguste  vähenemisest  private  label  -i  segmendis. Järgnevate kvartalite
puhul avaldab puhaskasumile negatiivset mõju laenude refinantseerimisest tulenev
kõrgem   intressikulu.  Samas  paraneb  rahavoog  aastas  ca  2 miljonit  eurot,
tingituna võlakirjade erinevast tagasimaksegraafikust võrreldes pangalaenuga.

Suurimat  mõju tulemustele avaldab kala  turuhinna langus.  Aruandeperioodi lõpu
seisuga  on lõhe turuhind võrreldes aastatagusega langenud 31,1% ja vikerforelli
hind  32,0%. Kahe aasta taguse hinnaga võrreldes  on lõhe hind langenud 43,2% ja
forell  läinud 31,7% odavamaks. Võrreldes perioodi lõpu hinda kolm aastat tagasi
on lõhe hind langenud 33,7% ja forelli hind 43,9%.

Finantsseisund

Ettevõtte  netovõlgnevus oli 17,0 miljonit eurot seisuga 31.03.2020 (31.03.2019:
18,7 miljonit  eurot). Grupi käibekapital oli seisuga 31.03.2020 negatiivne 2,5
miljoni  euro  võrra  kuna  lühiajalised  kohustused sisaldavad kohustusi seotud
osapooltele  summas 4,2 miljoni eurot,  mis oma olemuselt  on pikaajalised, kuid
raamatupidamise   arvestuspõhimõtete   tõttu   tuleb   näidata   lühiajalistena.
Raamatupidamisliku  mõju elimineerides on  käibekapital 1,7 milj. eurot. PRFoods
viis  edukalt lõpule võlakirjade  mitteavaliku emissiooni 2020. aasta jaanuaris,
mille   tulemusel   9 miljoni   euro   ulatuses   lühiajalisi  kohustusi  muutus
pikaajaliseks   vabastades   rahavooge   ca   2 miljoni   euro   võrra   aastas.
Võlastruktuuri   muutus   avaldab   mõju   ka   ettevõtte   majandustulemustele,
finantskulude  mõju  PRFoodsi  puhaskasumile  on  negatiivne 0,35 miljonit eurot
aastas.

Koroonaviiruse (Covid-19) pandeemia mõju

Covid-19 pandeemiast  tuleneva eriolukorra kehtestamise tõttu on ettevõtte käive
alates  märtsikuu keskpaigast märkimisväärselt  langenud HoReCa segmendis, mille
osakaal  Grupi käibest on ligikaudu 25%. Märtsi käibe langus antud segmendis oli
36% ning  aprillis  72%. Kuna  hotellid  ja  restoranid  on suletud või töötavad
osalise  koormusega  ning  seoses  koolide  distantsõppega  koolide lõpuüritused
jäävad  ära või toimuvad  piiratud mahus, siis  suure tõenäosusega antud sektori
müük  enne suve  keskpaika taastuma  ei hakka.  Olukorrast tingituna  on märgata
mõningast  jaekaubanduse  käibe  kasvu  (aprillis  8%), mis  aga  ei kata HoReCa
segmendi  langust ning pigem suureneb värske  kala ja kalafilee osakaal kuum- ja
külmsuitsutatud toodete asemel, mille kasumimarginaal on madalam.

Kuna  kriisi lõppu ja sellest taastumise  aega on äärmiselt keeruline ennustada,
siis   ei   ole  hetkel  võimalik  usaldusväärselt  hinnata  kriisi  finantsmõju
pikemaajaliselt.   Antud   olukorras   keskendub  Grupp  kulude  ja  rahavoogude
juhtimisele,  et  tagada  tegevuse  jätkusuutlikkus  ka  tulevikus. Kindlasti on
suurematel tööstustel nagu PRFoods parem toime tulla selliste kriisidega, samuti
on  ettevõtte tegevus  jaotunud mitme  turu vahel.  Osadel turgudel  eeldame oma
positsioonide tugevnemist konkurentsi vähenemise tõttu.

Grupi  ettevõtted on  vähendanud vastavalt  tootmise langusele  nii tootmis- kui
kontoritöötajate  tööaega  ja  töötasusid  vahemikus  10 -  30%. Grupi  juhatuse
esimehe  töötasu  on  vähendatud  kaheks  kuuks 50%. Ettevõte on aruandekuupäeva
järgselt Eestis kasutanud riigi poolt pakutavat töötasu kompenseerimise toetust.

2020. aasta   märtsikuus   viis  PRFoods  läbi  võlakirjade  emissiooni  avaliku
pakkumise,  mille perioodi  planeerimisel ei  osanud kriisi  ette näha, mistõttu
võlakirjade  märkimine jäi oodatust oluliselt madalamaks - 1,9 miljonist märgiti
0,9 miljonit  ehk 47% sh 0,5 milj. eurot PRFoodsi enda poolt märgitud võlakirjad
eesmärgiga need realiseerida pärast kriisi lõppu.

Finantsaasta sündmused ja tulevikuplaanid

Käesolevat  finantsaastat  jääb  mõjutama  Covid-19 ning  kindlasti näeme alanud
majanduskriisi mõjusid realiseerumas järgmisel finantsaastal.

PRFoodsi  jaoks on suurim mõju kala  turuhinnal. Aruandeperioodi lõpu seisuga on
lõhe  turuhind  võrreldes  aastatagusega  langenud  31,1% ja  vikerforelli  hind
32,0%. Kahe aasta taguse hinnaga võrreldes on lõhe hind langenud 43,2% ja forell
läinud 31,7% odavamaks. Võrreldes perioodi lõpu hinda kolm aastat tagasi on lõhe
hind  langenud 33,7% ja  forelli hind  43,9%.  Meie hinnangul  näeme 2020. aasta
puhul  tervikuna madalaid  kala hindu,  tingituna HoReCa  nõudluse vähenemisest.
Tarbijale  on  see  kindlasti  hea  uudis.  Vaatamata  osade  toodete suurenenud
tootmismahtudele  ja  nõudlusele,  ei  võimalda   madalamad hinnad absoluutarvus
teenida  nii suurt  kasumit. Samas  võimaldab madalam  hind oluliselt suurendada
ekspordimahte.  Arvestades  olukorda  vaatame  tulevikule  optimistlikumalt  kui
3.kvartali lõpus.

2020. aasta   suvel   viime   läbi   suurema   tootmise  automatiseerimise  ning
tooteportfelli   ümberkujundamise,   mis  võimaldab  ettevõttel  agressiivsemalt
tegutseda  nii koduturul  kui taasavada  suuremahuline eksport. 2019-2020 sügis-
talve perioodil viisime läbi Soome-Eesti ettevõtete juhtimise ümberkorraldamise,
millega  olid  seotud  märkimisväärsed  ühekordsed  kulud  ning  uute süsteemide
loomine mõjutas kindlasti ka müügitulemust.

Oleme  alates  4. kvartalist  juurutanud   kulude  kokkuhoiuprogrammi, mis peaks
andma meile aastas ca 0,4 miljonit eurot kokkuhoidu.

Järgmise  finantsaasta  alguses  planeerime  lõpule  viia ka võlakirjaemissiooni
täismahus.

Covid-19 on  tekitanud uue olukorra,  kuid vaatamata sellele  ei pidanud PRFoods
kordagi katkestama oma tootmist.

VÕTMENÄITAJAD

KASUMIARUANNE

+--------------+--------+--------+--------+--------+--------+--------+--------+--------+
|mln EUR       |1kv 2020|4kv 2019|3kv 2019|2kv 2019|1kv 2019|4kv 2018|3kv 2018|2kv 2018|
+--------------+--------+--------+--------+--------+--------+--------+--------+--------+
|Müügitulu     |    18,5|    25,4|    19,3|    21,5|    18,1|    26,7|    19,4|    22,1|
+--------------+--------+--------+--------+--------+--------+--------+--------+--------+
|Brutokasum    |     2,0|     4,3|     2,6|     2,1|     2,1|     4,7|     3,0|     1,8|
+--------------+--------+--------+--------+--------+--------+--------+--------+--------+
|EBITDA        |        |        |        |        |        |        |        |        |
|äritegevusest |     0,0|     2,1|     0,7|     0,3|     0,2|     2,4|     1,1|    -0,2|
+--------------+--------+--------+--------+--------+--------+--------+--------+--------+
|EBITDA        |    -0,9|     1,4|     1,5|     0,3|    -0,5|     0,8|     1,1|     0,3|
+--------------+--------+--------+--------+--------+--------+--------+--------+--------+
|EBIT          |    -1,4|     0,7|     1,0|    -0,3|    -1,0|     0,2|     0,6|    -0,2|
+--------------+--------+--------+--------+--------+--------+--------+--------+--------+
|EBT           |    -1,8|     0,6|     0,8|    -0,4|    -1,2|     0,0|     0,4|    -0,5|
+--------------+--------+--------+--------+--------+--------+--------+--------+--------+
|Puhaskasum (- |        |        |        |        |        |        |        |        |
|kahjum)       |    -1,7|     0,5|     0,6|    -0,6|    -1,2|     0,2|     0,1|    -1,1|
+--------------+--------+--------+--------+--------+--------+--------+--------+--------+
|Brutomarginaal|   10,8%|   17,0%|   13,4%|    9,8%|   11,7%|   17,7%|   15,2%|    7,9%|
+--------------+--------+--------+--------+--------+--------+--------+--------+--------+
|Äritegevuse   |        |        |        |        |        |        |        |        |
|EBITDA        |        |        |        |        |        |        |        |        |
|marginaal     |    0,1%|    8,4%|    3,8%|    1,4%|    1,1%|    9,1%|    5,4%|   -1,1%|
+--------------+--------+--------+--------+--------+--------+--------+--------+--------+
|EBITDA        |        |        |        |        |        |        |        |        |
|marginaal     |   -4,6%|    5,3%|    7,6%|    1,4%|   -2,5%|    2,9%|    5,8%|    1,2%|
+--------------+--------+--------+--------+--------+--------+--------+--------+--------+
|EBIT marginaal|   -7,8%|    2,9%|    5,0%|   -1,2%|   -5,6%|    0,9%|    3,0%|   -1,1%|
+--------------+--------+--------+--------+--------+--------+--------+--------+--------+
|EBT marginaal |   -9,8%|    2,2%|    3,9%|   -2,0%|   -6,5%|    0,1%|    1,8%|   -2,3%|
+--------------+--------+--------+--------+--------+--------+--------+--------+--------+
|Puhaskasumi   |        |        |        |        |        |        |        |        |
|marginaal     |   -9,2%|    2,0%|    2,9%|   -3,0%|   -6,6%|    0,8%|    0,7%|   -5,1%|
+--------------+--------+--------+--------+--------+--------+--------+--------+--------+
|Tegevuskulude |        |        |        |        |        |        |        |        |
|suhtarv       |   14,3%|   12,5%|   13,4%|   11,7%|   14,1%|   11,2%|   13,5%|   12,0%|
+--------------+--------+--------+--------+--------+--------+--------+--------+--------+

BILANSS

+-----------------+----------+----------+----------+----------+----------+----------+----------+
|mln EUR          |31.03.2020|31.12.2019|30.09.2019|30.06.2019|31.03.2019|31.12.2018|30.09.2018|
+-----------------+----------+----------+----------+----------+----------+----------+----------+
|Netovõlgnevus    |      17,0       17,8|      19,9|      20,5|      18,7|      20,0|      21,9|
+-----------------+---------------------+----------+----------+----------+----------+----------+
|Omakapital       |      21,6       23,3|      22,8|      21,9|      23,3|      24,2|      24,1|
+-----------------+---------------------+----------+----------+----------+----------+----------+
|Käibekapital     |      -2,5       -3,5|      -3,0|      -3,1|      -1,6|       1,0|       2,0|
+-----------------+---------------------+----------+----------+----------+----------+----------+
|Varad            |      56,9       60,5|      62,4|      62,5|      63,5|      65,5|      64,5|
+-----------------+---------------------+----------+----------+----------+----------+----------+
|Likviidsuskordaja|      0,9x       0,9x|      0,9x|      0,9x|      0,9x|      1,0x|      1,1x|
+-----------------+---------------------+----------+----------+----------+----------+----------+
|Omakapitali      |                     |          |          |          |          |          |
|suhtarv          |     37,9%      38,5%|     36,5%|     35,0%|     36,7%|     37,0%|     37,4%|
+-----------------+---------------------+----------+----------+----------+----------+----------+
|Finantsvõimendus |     44,0%      43,3%|     46,6%|     48,3%|     44,5%|     45,2%|     47,6%|
+-----------------+---------------------+----------+----------+----------+----------+----------+
|Võlakordaja      |      0,6x       0,6x|      0,6x|      0,7x|      0,6x|      0,6x|      0,6x|
+-----------------+---------------------+----------+----------+----------+----------+----------+
|Netovõlg / EBITDA|      5,3x       5,3x|      5,4x|      5,1x|      5,4x|      5,1x|      3,8x|
+-----------------+---------------------+----------+----------+----------+----------+----------+
|Omakapitali      |                     |          |          |          |          |          |
|tootlus          |     -5,7%      -3,2%|     -4,5%|     -6,5%|     -8,2%|     -4,0%|      0,1%|
+-----------------+---------------------+----------+----------+----------+----------+----------+
|Varade tootlus   |     -2,1%      -1,2%|     -1,6%|     -2,3%|     -3,0%|     -1,5%|      0,0%|
+-----------------+---------------------+----------+----------+----------+----------+----------+

Konsolideeritud finantsseisundi aruanne

+-------------------------------------+------------+------------+------------+
| Tuhandetes eurodes                  | 31.03.2020 | 31.03.2019 | 30.06.2019 |
+-------------------------------------+------------+------------+------------+
| VARAD                               |            |            |            |
+-------------------------------------+------------+------------+------------+
| Raha ja ekvivalendid                |      3 023 |      6 219 |      2 583 |
+-------------------------------------+------------+------------+------------+
| Nõuded ja ettemaksed                |      4 095 |      4 252 |      5 300 |
+-------------------------------------+------------+------------+------------+
| Varud                               |      9 656 |     11 409 |     11 980 |
+-------------------------------------+------------+------------+------------+
| Bioloogilised varad                 |      2 590 |      2 894 |      4 924 |
+-------------------------------------+------------+------------+------------+
| Käibevara kokku                     |     19 364 |     24 774 |     24 787 |
+-------------------------------------+------------+------------+------------+
|                                     |            |            |            |
+-------------------------------------+------------+------------+------------+
| Edasilükkunud tulumaksuvara         |         18 |         17 |         41 |
+-------------------------------------+------------+------------+------------+
| Pikaajalised finantsinvesteeringud  |        215 |        135 |        202 |
+-------------------------------------+------------+------------+------------+
| Materiaalne põhivara                |     14 135 |     14 842 |     14 535 |
+-------------------------------------+------------+------------+------------+
| Immateriaalne vara                  |     23 208 |     23 714 |     22 969 |
+-------------------------------------+------------+------------+------------+
| Põhivara kokku                      |     37 576 |     38 708 |     37 747 |
+-------------------------------------+------------+------------+------------+
| VARAD KOKKU                         |     56 940 |     63 482 |     62 534 |
+-------------------------------------+------------+------------+------------+
|                                     |            |            |            |
+-------------------------------------+------------+------------+------------+
| KOHUSTUSED JA OMAKAPITAL            |            |            |            |
+-------------------------------------+------------+------------+------------+
| Võlakohustused                      |      9 518 |     14 598 |     13 502 |
+-------------------------------------+------------+------------+------------+
| Võlad ja ettemaksed                 |     12 142 |     11 563 |     14 105 |
+-------------------------------------+------------+------------+------------+
| Sihtfinantseerimine                 |        187 |        245 |        234 |
+-------------------------------------+------------+------------+------------+
| Lühiajalised kohustused kokku       |     21 847 |     26 406 |     27 841 |
+-------------------------------------+------------+------------+------------+
|                                     |            |            |            |
+-------------------------------------+------------+------------+------------+
| Võlakohustused                      |     10 489 |     10 296 |      9 540 |
+-------------------------------------+------------+------------+------------+
| Võlad ja ettemaksed                 |        190 |        388 |        190 |
+-------------------------------------+------------+------------+------------+
| Edasilükkunud tulumaksukohustus     |      1 854 |      1 918 |      2 010 |
+-------------------------------------+------------+------------+------------+
| Sihtfinantseerimine                 |        962 |      1 198 |      1 087 |
+-------------------------------------+------------+------------+------------+
| Pikaajalised kohustused kokku       |     13 495 |     13 800 |     12 827 |
+-------------------------------------+------------+------------+------------+
| KOHUSTUSED KOKKU                    |     35 342 |     40 206 |     40 668 |
+-------------------------------------+------------+------------+------------+
|                                     |            |            |            |
+-------------------------------------+------------+------------+------------+
| Aktsiakapital                       |      7 737 |      7 737 |      7 737 |
+-------------------------------------+------------+------------+------------+
| Ülekurss                            |     14 007 |     14 007 |     14 007 |
+-------------------------------------+------------+------------+------------+
| Oma aktsiad                         |       -390 |       -390 |       -390 |
+-------------------------------------+------------+------------+------------+
| Kohustuslik reservkapital           |         51 |         51 |         51 |
+-------------------------------------+------------+------------+------------+
| Realiseerimata kursivahed           |        147 |        556 |       -214 |
+-------------------------------------+------------+------------+------------+
| Jaotamata kasum (-kahjum)           |       -550 |        576 |         66 |
+-------------------------------------+------------+------------+------------+
| Ettevõtte aktsionäridele kuuluv osa |     21 002 |     22 537 |     21 257 |
+-------------------------------------+------------+------------+------------+
| Väikeaktsionäridele kuuluv osa      |        596 |        739 |        609 |
+-------------------------------------+------------+------------+------------+
| OMAKAPITAL KOKKU                    |     21 598 |     23 276 |     21 866 |
+-------------------------------------+------------+------------+------------+
| OMAKAPITAL JA KOHUSTUSED KOKKU      |     56 940 |     63 482 |     62 534 |
+-------------------------------------+------------+------------+------------+

Konsolideeritud koondkasumiaruanne

+-----------------------+--------------+-------------+------------+------------+
|Tuhandetes eurodes     |              |        3kv  |            |            |
|                       |3kv  2019/2020|    2018/2019|9k 2019/2020|9k 2018/2019|
+-----------------------+--------------+-------------+------------+------------+
|Müügitulud             |        18 488|       18 120|      63 191|      64 242|
+-----------------------+--------------+-------------+------------+------------+
|Müüdud kaupade kulu    |       -16 497|      -15 999|     -54 293|     -54 447|
+-----------------------+--------------+-------------+------------+------------+
|Brutokasum             |         1 991|        2 121|       8 898|       9 795|
+-----------------------+--------------+-------------+------------+------------+
|                       |              |             |            |            |
+-----------------------+--------------+-------------+------------+------------+
|Tegevuskulud           |        -2 635|       -2 561|      -8 402|      -8 180|
+-----------------------+--------------+-------------+------------+------------+
|  Turundus- ja         |              |             |            |            |
|müügikulud             |        -1 735|       -1 775|      -5 673|      -5 702|
+-----------------------+--------------+-------------+------------+------------+
|  Üldhalduskulud       |          -900|         -786|      -2 729|      -2 478|
+-----------------------+--------------+-------------+------------+------------+
|Muud äritulud/-kulud   |           -35|         -114|         299|         189|
+-----------------------+--------------+-------------+------------+------------+
|Bioloogiliste varade   |              |             |            |            |
|ümberhindlus           |          -754|         -457|        -530|      -2 012|
+-----------------------+--------------+-------------+------------+------------+
|Ärikasum (-kahjum)     |        -1 433|       -1 011|         265|        -208|
+-----------------------+--------------+-------------+------------+------------+
|  Finantstulud/-kulud  |          -384|         -112|        -777|        -607|
+-----------------------+--------------+-------------+------------+------------+
|Maksustamiseelne kasum |              |             |            |            |
|(-kahjum)              |        -1 817|       -1 183|        -512|        -815|
+-----------------------+--------------+-------------+------------+------------+
|  Tulumaks             |           120|          -13|        -119|         -17|
+-----------------------+--------------+-------------+------------+------------+
|Aruandeperioodi        |              |             |            |            |
|puhaskasum (-kahjum)   |        -1 697|       -1 196|        -631|        -832|
+-----------------------+--------------+-------------+------------+------------+
|                       |              |             |            |            |
+-----------------------+--------------+-------------+------------+------------+
|Aruandeperioodi        |              |             |            |            |
|puhaskasumi (-kahjum)  |              |             |            |            |
|jaotus:                |              |             |            |            |
+-----------------------+--------------+-------------+------------+------------+
|emaettevõtte           |              |             |            |            |
|aktsionäridele kuuluv  |              |             |            |            |
|osa                    |        -1 658|       -1 177|        -616|        -948|
+-----------------------+--------------+-------------+------------+------------+
|Väikeaktsionäridele    |              |             |            |            |
|kuuluv osa             |           -39|          -19|         -15|         116|
+-----------------------+--------------+-------------+------------+------------+
|Aruandeperioodi        |              |             |            |            |
|puhaskasumi (-kahjum)  |              |             |            |            |
|kokku                  |        -1 697|       -1 196|        -631|        -832|
+-----------------------+--------------+-------------+------------+------------+
|                       |              |             |            |            |
+-----------------------+--------------+-------------+------------+------------+
|Muu koondkasum (-      |              |             |            |            |
|kahjum), mida võib     |              |             |            |            |
|hiljem klassifitseerida|              |             |            |            |
|kasumiaruandesse:      |              |             |            |            |
+-----------------------+--------------+-------------+------------+------------+
|Valuutakursi vahed     |           -20|          626|         361|         549|
+-----------------------+--------------+-------------+------------+------------+
|Kokku koondkasum (-    |              |             |            |            |
|kahjum)                |        -1 717|         -570|        -270|        -283|
+-----------------------+--------------+-------------+------------+------------+
|                       |              |             |            |            |
+-----------------------+--------------+-------------+------------+------------+
|Aruandeperioodi        |              |             |            |            |
|koondkasumi (-kahjum)  |              |             |            |            |
|jaotus:                |              |             |            |            |
+-----------------------+--------------+-------------+------------+------------+
|emaettevõtte           |              |             |            |            |
|aktsionäridele kuuluv  |              |             |            |            |
|osa                    |        -1 684|         -551|        -255|        -399|
+-----------------------+--------------+-------------+------------+------------+
|Väikeaktsionäridele    |              |             |            |            |
|kuuluv osa             |           -33|          -19|         -15|         116|
+-----------------------+--------------+-------------+------------+------------+
|Aruandeperioodi        |              |             |            |            |
|koondkasum (-kahjum)   |              |             |            |            |
|kokku                  |        -1 717|         -570|        -270|        -283|
+-----------------------+--------------+-------------+------------+------------+
|                       |              |             |            |            |
+-----------------------+--------------+-------------+------------+------------+
|Tava puhaskasum (-     |              |             |            |            |
|kahjum) aktsia kohta   |              |             |            |            |
|(EUR)                  |         -0,04|        -0,01|       -0,01|       -0,01|
+-----------------------+--------------+-------------+------------+------------+
|                       |              |             |            |            |
+-----------------------+--------------+-------------+------------+------------+
|Lahustatud puhaskasum  |              |             |            |            |
|(-kahjum) aktsia kohta |              |             |            |            |
|(EUR)                  |         -0,04|        -0,01|       -0,01|       -0,01|
+-----------------------+--------------+-------------+------------+------------+

Indrek Kasela

 AS PRFoods

 Juhatuse liige

 T: +372 452 1470

 [email protected]

 www.prfoods.ee?

Content of announcement in English

Title

PRF: Consolidated Unaudited Interim Report of AS PRFoods for the 3rd quarter and 9 months of 2019/2020 financial year

Message

OVERVIEW OF ECONOMIC ACTIVITIES

MANAGEMENT COMMENTARY

The 3rd quarter of the financial year ended with a 2% sales growth for PRFoods,
the total turnover was 18.5 million euros (9 months 63.2 million euros). 9-month
EBITDA increased by 35% to 2 million euros and net loss decreased by 25% to 0.6
million euros compared to the same period last year.

The end of the quarter brought a global pandemic to our key markets, and
restrictions of the states of emergencies declared began to take effect. HoReCa
restrictions and a drastic reduction in air transport had a significant impact
on turnover as early as at the end of March. Also, as during any crisis,
customers made changes to their food baskets in favour of cheaper products.
PRFoods withstood the Covid-19 pandemic with a strengthened balance sheet, as we
had just refinanced our short-term loans with secured bonds and we have also
improved our cash flows due to a smaller raw material inventory. Major changes
are expected in the fourth quarter, but we see that at least in June, HoReCa
(share of 25% of the Group's turnover) is partially recovering and the food
industry is in a safer position than many other sectors. The effect of Covid-19
on the financial results of PRFoods is reflected in the financial statements of
the 4th quarter and 12 months of the financial year.

The Group's revenue

The Group's unaudited consolidated turnover in the 3rd quarter of the financial
year (i.e. the 1st quarter of 2020) was 18.5 million euros, increasing by 2%
compared to the same period of the previous year (Q1 2019: 18.2 million euros).
The Group's turnover for the first 9 months of the financial year was 63.2
million euros remaining almost at the same level as in the same period of the
previous year (9 months 2018/2019: 64.2 million euros). In the first quarter of
the year, sales of fresh fish and fish fillets increased by 24% and sales of
smoked products decreased by 12% compared to the same period last year. March
sales were significantly affected by the decline in sales in the HoReCa segment
(36%) due to the states of emergencies declared due to the Covid-19 pandemic in
both Finland and Estonia.

In the first 9 months of the financial year, the share of raw fish and fillets
in the product portfolio has increased to 45% (increase of 4 pp compared to the
same period last year) and the share of smoked products has decreased to 38%
(decrease of 5 pp, respectively).

Sales of fresh fish and fillets have been higher than usual in the
aforementioned period, while the margin of fresh fish is about twice lower than
the margin of smoked products.

Results of the financial year's 3(rd) quarter and 9 months

The Group's 9-month consolidated EBITDA was 2.0 million euros (9 months
2018/2019: 1.5 million euros), increasing by 35% compared to the previous year,
mainly due to the positive effect of the revaluation of biological assets.
EBITDA from operating activities (i.e. before non-recurring income-expenses and
revaluation of fish stocks) was 2.9 million euros (9 months 2018/2019: 3.7
million euros). The net loss was 0.6 million euros (9 months 2018/2019 net loss:
0.8 million euros).

EBITDA from operations for the 3rd quarter of the financial year was 0.03
million euros (3rd quarter 2018/2019: 0.21 million euros) and net loss 1.7
million euros, increasing by 0.5 million euros (3rd quarter 2018/2019: -1.2
million euros).   Negative impact from revaluation of biological assets 0.75
million euros (3Q 2018/2019: negative impact 0.46 million euros). The reasons
for the higher financial expenses during the reporting period are the higher
bond interest rate (6.25%) than the loan interest rate (3.25%) (negative impact
on the quarterly profit of 0.03 million euros) and the exchange rate loss due to
the weakening of the Swedish krona (-0.15 million euros).

The growth of the group's EBITDA by 35% to 2 million by the end of the 3rd
quarter is positive, mainly due to the growth of biological assets. EBITDA from
operations was affected by the decrease in the share of smoked products in
sales, which was due to the decrease in sales volumes in the private label
segment in Finland at the beginning of the year. In the following quarters, the
refinancing of loans will have a negative impact on the net profit caused by
higher interest rate. At the same time, the cash flow will improve by
approximately 2 million euros per year due to the different repayment schedule
of the bonds compared to the bank loan.

The greatest impact on the results has the decline in the market price of fish.
At the end of the reporting period, the market price of salmon has decreased by
31.1% and the price of rainbow trout by 32.0% compared to a year ago. Compared
to the price two years ago, the price of salmon has decreased by 43.2% and trout
has become 31.7% cheaper. Compared to the end-of-period price three years ago,
the price of salmon has fallen by 33.7% and the price of trout by 43.9%.

Financial position

The company's net debt was 17.0 million euros as of 31.03.2020 (31.03.2019:
18.7 million euros). As of 31.03.2020, the Group's working capital was negative
by 2.5 million euros as current liabilities include liabilities to related
parties in the amount of 4.2 million euros, which are long-term in nature, but
due to accounting principles must be shown as current. Eliminating the
accounting effect, the working capital is 1.7 million euros. PRFoods
successfully completed the non-public issue of bonds in January 2020, as a
result of which short-term liabilities in the amount of 9 million euros became
long-term, releasing cash flows by approximately 2 million euros per year. The
change in the debt structure also has an impact on the company's financial
results, the financial expenses' impact on PRFoods' net profit is negative by
0.35 million euros per year.

Impact of the coronavirus (Covid-19) pandemic

Due to the declaration of the state of emergency caused by Covid-19 pandemic,
the company's turnover has significantly decreased in the HoReCa segment since
mid-March, which accounts for approximately 25% of the Group's turnover. The
decrease in turnover in this segment was 36% in March and 72% in April. As
hotels and restaurants are closed or operating only part-time, and distance
learning resulting in school graduation events to be cancelled or carried out in
limited scopes, sales in this sector are unlikely to recover until mid-summer.
Due to the situation, there is a slight increase in retail sales (8% in April),
which does not cover the decline in the HoReCa segment and increases the share
of fresh fish and fish fillets instead of hot and cold smoked products with
lower profit margins.

As it is extremely difficult to predict the end of the crisis and the time to
recover from it, it is currently not possible to reliably assess the long-term
financial impact of the crisis. In this situation, the Group focuses on cost and
cash flow management to ensure the sustainability of its operations in the
future. Larger industries, such as PRFoods, are most certainly better able to
cope with such crises, also, the company's activities are spread across several
markets. In some markets we expect our positions to strengthen as a result of
reduced competition.

Following the decline in production, the Group's companies have reduced the
working hours and salaries of both production and office employees by between
10 and 30%. The remuneration of the chairman of the management board has been
reduced by 50% for two months. After the reporting date, the company has used
the salary compensation support offered by the Estonian state.

In March 2020, PRFoods conducted a public offering of bond issues. While
planning the period of the issue, the crisis occurring at the time of the issue
period could not have been foreseen, which is why the subscription of bonds was
significantly lower than expected - 0.9 million or 47% of the 1.9 million,
including 0.5 million bonds subscribed by PRFoods with a perspective to sell
these after the end of the crisis.

Events and the future plans for the financial year

This financial year will continue to be affected by Covid-19, and we will
certainly see the effects of the current economic crisis materialize in the next
financial year.

For PRFoods, the biggest impact is on the market price of fish. At the end of
the reporting period, the market price of salmon has decreased by 31.1% and the
price of rainbow trout by 32.0% compared to a year ago. Compared to the price
two years ago, the price of salmon has decreased by 43.2% and trout has become
31.7% cheaper. Compared to the end-of-period price three years ago, the price of
salmon has fallen by 33.7% and the price of trout by 43.9%. We estimate that we
will see low fish prices for 2020 as a whole, due to declining demand for
HoReCa. This is definitely good news for consumers. Despite increased production
volumes and demand for some products, lower prices do not allow such a large
profit to be made in absolute terms. At the same time, the lower price allows to
significantly increase export volumes. Considering the situation, we look more
optimistically to the future than at the end of the 3rd quarter.

In the summer of 2020, we will carry out greater automation of production and
reorganization of the product portfolio, which will enable the company to
operate more aggressively both in the domestic market and to reopen large-scale
exports. In the autumn-winter period of 2019-2020, we carried out a
reorganization of the management of Finnish-Estonian companies, which involved
significant one-time costs, and the creation of new systems certainly affected
the sales result.

We have implemented a cost savings program since the 4th quarter, which should
save us about 0.4 million euros a year.

At the beginning of the next financial year, we also plan to complete the bond
issue in full.

Covid-19 has created a new situation, but PRFoods has never had to stop
production.

KEY RATIOS

INCOME STATEMENT

+--------------+-------+-------+-------+-------+-------+-------+-------+-------+
|mln EUR       |1Q 2020|4Q 2019|3Q 2019|2Q 2019|1Q 2019|4Q 2018|3Q 2018|2Q 2018|
+--------------+-------+-------+-------+-------+-------+-------+-------+-------+
|Sales         |   18,5|   25.4|   19,3|   21.5|   18.1|   26.7|   19.4|   22.1|
+--------------+-------+-------+-------+-------+-------+-------+-------+-------+
|Gross profit  |    2,0|    4.3|    2,6|    2.1|    2.1|    4.7|    3.0|    1.8|
+--------------+-------+-------+-------+-------+-------+-------+-------+-------+
|EBITDA from   |       |       |       |       |       |       |       |       |
|operations    |    0,0|    2.1|    0,7|    0.3|    0.2|    2.4|    1.1|   -0.2|
+--------------+-------+-------+-------+-------+-------+-------+-------+-------+
|EBITDA        |   -0,9|    1.4|    1,5|    0.3|   -0.5|    0.8|    1.1|    0.3|
+--------------+-------+-------+-------+-------+-------+-------+-------+-------+
|EBIT          |   -1,4|    0.7|    1,0|   -0.3|   -1.0|    0.2|    0.6|   -0.2|
+--------------+-------+-------+-------+-------+-------+-------+-------+-------+
|EBT           |   -1,8|    0.6|    0,8|   -0.4|   -1.2|    0.0|    0.4|   -0.5|
+--------------+-------+-------+-------+-------+-------+-------+-------+-------+
|Net profit (- |       |       |       |       |       |       |       |       |
|loss)         |   -1,7|    0.5|    0,6|   -0.6|   -1.2|    0.2|    0.1|   -1.1|
+--------------+-------+-------+-------+-------+-------+-------+-------+-------+
|Gross margin  |  10,8%|  17.0%|  13,4%|   9.8%|  11.7%|  17.7%|  15.2%|   7.9%|
+--------------+-------+-------+-------+-------+-------+-------+-------+-------+
|Operational   |       |       |       |       |       |       |       |       |
|EBITDA margin |   0,1%|   8.4%|   3,8%|   1.4%|   1.1%|   9.1%|   5.4%|  -1.1%|
+--------------+-------+-------+-------+-------+-------+-------+-------+-------+
|EBITDA margin |  -4,6%|   5.3%|   7,6%|   1.4%|  -2.5%|   2.9%|   5.8%|   1.2%|
+--------------+-------+-------+-------+-------+-------+-------+-------+-------+
|EBIT margin   |  -7,8%|   2.9%|   5,0%|  -1.2%|  -5.6%|   0.9%|   3.0%|  -1.1%|
+--------------+-------+-------+-------+-------+-------+-------+-------+-------+
|EBT margin    |  -9,8%|   2.2%|   3,9%|  -2.0%|  -6.5%|   0.1%|   1.8%|  -2.3%|
+--------------+-------+-------+-------+-------+-------+-------+-------+-------+
|Net margin    |  -9,2%|   2.0%|   2,9%|  -3.0%|  -6.6%|   0.8%|   0.7%|  -5.1%|
+--------------+-------+-------+-------+-------+-------+-------+-------+-------+
|Operating     |       |       |       |       |       |       |       |       |
|expense ratio |  14,3%|  12.5%|  13,4%|  11.7%|  14.1%|  11.2%|  13.5%|  12.0%|
+--------------+-------+-------+-------+-------+-------+-------+-------+-------+

BALANCE SHEET

+---------+----------+----------+----------+----------+----------+----------+----------+
|mln EUR  |31.03.2020|31.12.2019|30.09.2019|30.06.2019|31.03.2019|31.12.2018|30.09.2018|
+---------+----------+----------+----------+----------+----------+----------+----------+
|Net debt |      17,0       17.8|      19,9|      20.5|      18.7|      20.0|      21.9|
+---------+---------------------+----------+----------+----------+----------+----------+
|Equity   |      21,6       23.3|      22,8|      21.9|      23.3|      24.2|      24.1|
+---------+---------------------+----------+----------+----------+----------+----------+
|Working  |                     |          |          |          |          |          |
|capital  |      -2,5       -3.5|      -3,0|      -3.1|      -1.6|       1.0|       2.0|
+---------+---------------------+----------+----------+----------+----------+----------+
|Assets   |      56,9       60.5|      62,4|      62.5|      63.5|      65.5|      64.5|
+---------+---------------------+----------+----------+----------+----------+----------+
|Liquidity|                     |          |          |          |          |          |
|ratio    |      0,9x       0.9x|      0,9x|      0.9x|      0.9x|      1.0x|      1.1x|
+---------+---------------------+----------+----------+----------+----------+----------+
|Equity   |                     |          |          |          |          |          |
|ratio    |     37,9%      38.5%|     36,5%|     35.0%|     36.7%|     37.0%|     37.4%|
+---------+---------------------+----------+----------+----------+----------+----------+
|Gearing  |                     |          |          |          |          |          |
|ratio    |     44,0%      43.3%|     46,6%|     48.3%|     44.5%|     45.2%|     47.6%|
+---------+---------------------+----------+----------+----------+----------+----------+
|Debt to  |                     |          |          |          |          |          |
|total    |                     |          |          |          |          |          |
|assets   |      0,6x       0.6x|      0,6x|      0.7x|      0.6x|      0.6x|      0.6x|
+---------+---------------------+----------+----------+----------+----------+----------+
|Net debt |                     |          |          |          |          |          |
|to EBITDA|      5,3x       5.3x|      5,4x|      5.1x|      5.4x|      5.1x|      3.8x|
+---------+---------------------+----------+----------+----------+----------+----------+
|ROE      |     -5,7%      -3.2%|     -4,5%|     -6.5%|     -8.2%|     -4.0%|      0.1%|
+---------+---------------------+----------+----------+----------+----------+----------+
|ROA      |     -2,1%      -1.2%|     -1,6%|     -2.3%|     -3.0%|     -1.5%|      0.0%|
+---------+---------------------+----------+----------+----------+----------+----------+

Consolidated Statement of Financial Position

+---------------------------------+------------+------------+------------+
| Thousand euros                  | 31.03.2020 | 31.03.2019 | 30.06.2019 |
+---------------------------------+------------+------------+------------+
| ASSETS                          |            |            |            |
+---------------------------------+------------+------------+------------+
| Cash and cash equivalents       |      3,023 |      6,219 |      2,583 |
+---------------------------------+------------+------------+------------+
| Receivables and prepayments     |      4,095 |      4,252 |      5,300 |
+---------------------------------+------------+------------+------------+
| Inventories                     |      9,656 |     11,409 |     11,980 |
+---------------------------------+------------+------------+------------+
| Biological assets               |      2,590 |      2,894 |      4,924 |
+---------------------------------+------------+------------+------------+
| Total current assets            |     19,364 |     24,774 |     24,787 |
+---------------------------------+------------+------------+------------+
|                                 |            |            |            |
+---------------------------------+------------+------------+------------+
| Deferred income tax             |         18 |         17 |         41 |
+---------------------------------+------------+------------+------------+
| Long-term financial investments |        215 |        135 |        202 |
+---------------------------------+------------+------------+------------+
| Tangible fixed assets           |     14,135 |     14,842 |     14,535 |
+---------------------------------+------------+------------+------------+
| Intangible assets               |     23,208 |     23,714 |     22,969 |
+---------------------------------+------------+------------+------------+
| Total non-current assets        |     37,576 |     38,708 |     37,747 |
+---------------------------------+------------+------------+------------+
| TOTAL ASSETS                    |     56,940 |     63,482 |     62,534 |
+---------------------------------+------------+------------+------------+
|                                 |            |            |            |
+---------------------------------+------------+------------+------------+
| EQUITY AND LIABILITIES          |            |            |            |
+---------------------------------+------------+------------+------------+
| Loans and borrowings            |      9,518 |     14,598 |     13,502 |
+---------------------------------+------------+------------+------------+
| Payables                        |     12,142 |     11,563 |     14,105 |
+---------------------------------+------------+------------+------------+
| Government grants               |        187 |        245 |        234 |
+---------------------------------+------------+------------+------------+
| Total current liabilities       |     21,847 |     26,406 |     27,841 |
+---------------------------------+------------+------------+------------+
|                                 |            |            |            |
+---------------------------------+------------+------------+------------+
| Loans and borrowings            |     10,489 |     10,296 |      9,540 |
+---------------------------------+------------+------------+------------+
| Payables                        |        190 |        388 |        190 |
+---------------------------------+------------+------------+------------+
| Deferred tax liabilities        |      1,854 |      1,918 |      2,010 |
+---------------------------------+------------+------------+------------+
| Government grants               |        962 |      1,198 |      1,087 |
+---------------------------------+------------+------------+------------+
| Total non-current liabilities   |     13,495 |     13,800 |     12,827 |
+---------------------------------+------------+------------+------------+
| TOTAL LIABILITIES               |     35,342 |     40,206 |     40,668 |
+---------------------------------+------------+------------+------------+
|                                 |            |            |            |
+---------------------------------+------------+------------+------------+
| Share capital                   |      7,737 |      7,737 |      7,737 |
+---------------------------------+------------+------------+------------+
| Share premium                   |     14,007 |     14,007 |     14,007 |
+---------------------------------+------------+------------+------------+
| Treasury shares                 |       -390 |       -390 |       -390 |
+---------------------------------+------------+------------+------------+
| Statutory capital reserve       |         51 |         51 |         51 |
+---------------------------------+------------+------------+------------+
| Currency translation reserve    |        147 |        556 |       -214 |
+---------------------------------+------------+------------+------------+
| Retained profit (-loss)         |       -550 |        576 |         66 |
+---------------------------------+------------+------------+------------+
| Equity attributable to parent   |     21,002 |     22,537 |     21,257 |
+---------------------------------+------------+------------+------------+
| Non-controlling interest        |        596 |        739 |        609 |
+---------------------------------+------------+------------+------------+
| TOTAL EQUITY                    |     21,598 |     23,276 |     21,866 |
+---------------------------------+------------+------------+------------+
| TOTAL EQUITY AND LIABILITIES    |     56,940 |     63,482 |     62,534 |
+---------------------------------+------------+------------+------------+

Consolidated Statement of Profit or Loss And Other Comprehensive Income

+--------------------------+------------+------------+------------+------------+
|Thousand euros            |3Q 2019/2020|3Q 2018/2019|9m 2019/2020|9m 2018/2019|
+--------------------------+------------+------------+------------+------------+
|Sales                     |      18,488|      18,120|      63,191|      64,242|
+--------------------------+------------+------------+------------+------------+
|Cost of goods sold        |     -16,497|     -15,999|     -54,293|     -54,447|
+--------------------------+------------+------------+------------+------------+
|Gross profit              |       1,991|       2,121|       8,898|       9,795|
+--------------------------+------------+------------+------------+------------+
|                          |            |            |            |            |
+--------------------------+------------+------------+------------+------------+
|Operating expenses        |      -2,635|      -2,561|      -8,402|      -8,180|
+--------------------------+------------+------------+------------+------------+
|  Selling and distribution|            |            |            |            |
|expenses                  |      -1,735|      -1,775|      -5,673|      -5,702|
+--------------------------+------------+------------+------------+------------+
|  Administrative expenses |        -900|        -786|      -2,729|      -2,478|
+--------------------------+------------+------------+------------+------------+
|Other income / expense    |         -35|        -114|         299|         189|
+--------------------------+------------+------------+------------+------------+
|Fair value adjustment on  |            |            |            |            |
|biological assets         |        -754|        -457|        -530|      -2,012|
+--------------------------+------------+------------+------------+------------+
|Operating profit (loss)   |      -1,433|      -1,011|         265|        -208|
+--------------------------+------------+------------+------------+------------+
|Financial income/-expenses|        -384|        -112|        -777|        -607|
+--------------------------+------------+------------+------------+------------+
|Profit (loss) before tax  |      -1,817|      -1,183|        -512|        -815|
+--------------------------+------------+------------+------------+------------+
|Income tax                |         120|         -13|        -119|         -17|
+--------------------------+------------+------------+------------+------------+
|Net profit (loss) for the |            |            |            |            |
|period                    |      -1,697|      -1,196|        -631|        -832|
+--------------------------+------------+------------+------------+------------+
|                          |            |            |            |            |
+--------------------------+------------+------------+------------+------------+
|Net profit (loss)         |            |            |            |            |
|attributable to:          |            |            |            |            |
+--------------------------+------------+------------+------------+------------+
|Owners of the company     |      -1,658|      -1,177|        -616|        -948|
+--------------------------+------------+------------+------------+------------+
|Non-controlling interests |         -39|         -19|         -15|         116|
+--------------------------+------------+------------+------------+------------+
|Total net profit (loss)   |      -1,697|      -1,196|        -631|        -832|
+--------------------------+------------+------------+------------+------------+
|                          |            |            |            |            |
+--------------------------+------------+------------+------------+------------+
|Other comprehensive income|            |            |            |            |
|(loss) that may           |            |            |            |            |
|subsequently be classified|            |            |            |            |
|to profit or loss:        |            |            |            |            |
+--------------------------+------------+------------+------------+------------+
|Foreign currency          |            |            |            |            |
|translation differences   |         -20|         626|         361|         549|
+--------------------------+------------+------------+------------+------------+
|Total comprehensive income|            |            |            |            |
|(expense)                 |      -1,717|        -570|        -270|        -283|
+--------------------------+------------+------------+------------+------------+
|                          |            |            |            |            |
+--------------------------+------------+------------+------------+------------+
|Total comprehensive income|            |            |            |            |
|(expense) attributable to:|            |            |            |            |
+--------------------------+------------+------------+------------+------------+
|Owners of the Company     |      -1,684|        -551|        -255|        -399|
+--------------------------+------------+------------+------------+------------+
|Non-controlling interests |         -33|         -19|         -15|         116|
+--------------------------+------------+------------+------------+------------+
|Total comprehensive income|            |            |            |            |
|(expense) for the period  |      -1,717|        -570|        -270|        -283|
+--------------------------+------------+------------+------------+------------+
|                          |            |            |            |            |
+--------------------------+------------+------------+------------+------------+
|Profit (loss) per share   |            |            |            |            |
|(EUR)                     |       -0.04|       -0.01|       -0.01|       -0,01|
+--------------------------+------------+------------+------------+------------+
|                          |            |            |            |            |
+--------------------------+------------+------------+------------+------------+
|Diluted profit (loss) per |            |            |            |            |
|share (EUR)               |       -0.04|       -0.01|       -0.01|       -0,01|
+--------------------------+------------+------------+------------+------------+

Indrek Kasela

 AS PRFoods

 Member of the Management Board

 Phone: +372 452 1470

 [email protected]

 www.prfoods.ee